Card image cap

Rosa DeLauro's Public Statements on Issue: Drugs

Office:

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 6
Date Title
04/14/2021 Reps. Porter, DeLauro Reintroduce Legislation to Protect Patients from Paying More for Drugs
06/06/2020 Letter to Hon. Chad Wolf, Acting Secretary of the Department of Homeland Security - Congressmen Norcross, Chabot Lead Call for Release of Appropriated Funds for U.S. Coast Guard National Security Cutter
04/01/2020 DeLauro Statement on FDA Calling for Market Withdrawal of All Ranitidine Products
01/28/2020 Letter to the Hon. Sonny Perdue, Secretary of the U.S. Dept. of Agriculture, and the Hon. Bruce Summers, Admin. of the Agricultural Marketing Service - Commissioner Bryan Hurlburt And Rep. Joe Courtney Lead Connecticut Congressional Delegation To Urge Changes On USDA's Hemp Production Rules
02/12/2019 DeLauro Welcomes FDA Action on Oversight of Dietary Supplements
07/31/2018 Letter to Dr. Robert R. Redfield, Director of the Centers for Disease Control and Prevention - Linda Sánchez Leads Bipartisan Letter to Help Secure CDC Funding for Major U.S. Cities to Fight Opioid Crisis
06/13/2018 Personal Explanation
10/29/2017 DeLauro Statement on Gov. Christie's Call to Fund the Public Health Emergency Fund to Fight the Opioid Epidemic
10/26/2017 DeLauro, Lowey Demand Increased Funding to Address the Opioid Epidemic Following Trump's Insufficient Action
08/30/2017 DeLauro Reiterates Call for Public Health Emergency Funding to Address Opioid Epidemic
08/11/2017 DeLauro Calls for Public Health Emergency Funding to Address Opioid Epidemic
07/28/2017 DeLauro Statement on FDA's Regulatory Plan for Tobacco Products
04/21/2017 Connecticut Congressional Delegation Announces $5.5 Million Federal Grant to Combat Opioid Crisis
04/04/2017 Letter to the Hon. Donald Trump, President of the United States - Lower Prescription Drug Prices
03/29/2017 Schakowsky, Cummings, DeLauro, and Welch Introduce Comprehensive Bill to Address Drug Pricing
02/21/2017 Letter to the Hon. Spencer Williamson, President and CEO of Kaleo Pharmaceuticals - Demanding Answers to Recent Naloxone Price Spike
12/13/2016 Report: Prescription Drug Prices Driving Up Health Care Costs
09/06/2016 Larson, Blumenthal, Murphy, DeLauro, and Courtney Announce $700,000 in Federal Funding to Prevent Youth Substance Abuse
05/13/2016 DeLauro Statement On Opioid Bills Passed In The House Of Representatives
05/04/2016 Letter to the Hon. Paul Ryan, Speaker of the House - Consider Emergency Funding To Address Opioid And Heroin Epidemic
04/29/2016 DeLauro Announces National Take-Back Day Locations In Connecticut
04/19/2016 Reps. Roybal-Allard, DeLauro Lead Amendment to Regulate Premium Cigars
04/11/2016 DeLauro Holds Forum On Expanding Access To Opioid Treatment
03/28/2016 Letter to the Honorable Sylvia M. Burwell, Secretary of Health and Human Services and Francis Collins, Director of National Institutes of Health - Act Now on Drug Affordability
03/20/2016 DeLauro holds New Haven discussion, film screening on opioid crisis
Page 1 of 6
arrow_upward